Mucormycosis-A serious threat in the COVID-19 pandemic?

J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.015. Epub 2021 May 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antifungal Agents / therapeutic use
  • COVID-19*
  • Humans
  • Mucormycosis* / diagnosis
  • Mucormycosis* / drug therapy
  • Mucormycosis* / epidemiology
  • Pandemics
  • SARS-CoV-2

Substances

  • Antifungal Agents